Paper
27 February 2009 Choline molecular imaging with small-animal PET for monitoring tumor cellular response to photodynamic therapy of cancer
Baowei Fei, Hesheng Wang, Chunying Wu, Joseph Meyers, Liang-Yan Xue, Gregory MacLennan, Mark Schluchter
Author Affiliations +
Abstract
We are developing and evaluating choline molecular imaging with positron emission tomography (PET) for monitoring tumor response to photodynamic therapy (PDT) in animal models. Human prostate cancer (PC-3) was studied in athymic nude mice. A second-generation photosensitizer Pc 4 was used for PDT in tumor-bearing mice. MicroPET images with 11C-choline were acquired before PDT and 48 h after PDT. Time-activity curves of 11C-choline uptake were analyzed before and after PDT. For treated tumors, normalized choline uptake decreased significantly 48 h after PDT, compared to the same tumors pre-PDT (p ⪅ 0.001). However, for the control tumors, normalized choline uptake increased significantly (p ⪅ 0.001). PET imaging with 11C-choline is sensitive to detect early tumor response to PDT in the animal model of human prostate cancer.
© (2009) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Baowei Fei, Hesheng Wang, Chunying Wu, Joseph Meyers, Liang-Yan Xue, Gregory MacLennan, and Mark Schluchter "Choline molecular imaging with small-animal PET for monitoring tumor cellular response to photodynamic therapy of cancer", Proc. SPIE 7262, Medical Imaging 2009: Biomedical Applications in Molecular, Structural, and Functional Imaging, 726211 (27 February 2009); https://doi.org/10.1117/12.812129
Lens.org Logo
CITATIONS
Cited by 3 scholarly publications.
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Tumors

Photodynamic therapy

Positron emission tomography

Cancer

Animal model studies

Prostate cancer

Tumor growth modeling

Back to Top